|
|
||||||||
B During Primary B Cell Differentiation1



*
MSZ, Institut für Medizinische Strahlenkunde und Zellforschung, and
Pathologisches Institut, Universität Würzburg, Wurzburg, Germany;
Institute for Immunology, Basel, Switzerland
We have investigated activation of nuclear factor-
B (NF-
B) in
the process of primary B cell differentiation in vitro. In this system,
NF-
B is strongly induced when B cells develop from the pre-B cell to
the immature B cell stage. Unlike the typical NF-
B activation in
response to exogenous stimuli, induction proceeds with a slow time
course. NF-
B induction is only observed in B cells that undergo
differentiation, not in Rag2-deficient cells. Nuclear DNA binding
complexes predominantly comprise p50/RelA heterodimers and, to a lesser
extent, c-Rel-containing dimers. The increase in NF-
B binding
activity is accompanied by a slow and steady decrease in I
Bß
protein levels. Interestingly, absolute RelA protein levels remain
unaffected, whereas RelB and c-Rel synthesis is induced. The reason for
preferential nuclear translocation of RelA complexes appears to be
selective inhibition by the I
Bß protein. I
Bß can efficiently
inhibit p50/RelA complexes, but has a much reduced ability to interfere
with p50/c-Rel DNA binding both in vitro and in vivo. Interestingly,
p50/RelB complexes are not at all targeted by I
Bß, and
coimmunoprecipitation experiments show no evidence for an association
of I
Bß and RelB in vivo. Consistent with these observations,
I
Bß cotransfection can inhibit p50/RelA-mediated
trans-activation, but barely affects p50/RelB mediated
trans-activation.
This article has been cited by other articles:
![]() |
E. Vigorito, L. Gambardella, F. Colucci, S. McAdam, and M. Turner Vav proteins regulate peripheral B-cell survival Blood, October 1, 2005; 106(7): 2391 - 2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Cejas, L. M. Carlson, D. Kolonias, J. Zhang, I. Lindner, D. D. Billadeau, L. H. Boise, and K. P. Lee Regulation of RelB Expression during the Initiation of Dendritic Cell Differentiation Mol. Cell. Biol., September 1, 2005; 25(17): 7900 - 7916. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Maier, R. Marienfeld, T. Wirth, and B. Baumann Critical Role of RelB Serine 368 for Dimerization and p100 Stabilization J. Biol. Chem., October 3, 2003; 278(40): 39242 - 39250. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Marienfeld, M. J. May, I. Berberich, E. Serfling, S. Ghosh, and M. Neumann RelB Forms Transcriptionally Inactive Complexes with RelA/p65 J. Biol. Chem., May 23, 2003; 278(22): 19852 - 19860. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, R. Ouchida, T. Kodama, T. Kawashima, Y. Makino, N. Yoshikawa, S. Watanabe, C. Morimoto, T. Kitamura, and H. Tanaka Cytokine Receptor Common beta Subunit-mediated STAT5 Activation Confers NF-kappa B Activation in Murine proB Cell Line Ba/F3 Cells J. Biol. Chem., February 15, 2002; 277(8): 6254 - 6265. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Tam, W. Wang, and R. Sen Cell-Specific Association and Shuttling of I{kappa}B{alpha} Provides a Mechanism for Nuclear NF-{kappa}B in B Lymphocytes Mol. Cell. Biol., July 15, 2001; 21(14): 4837 - 4846. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hess, P. J. Nielsen, K.-D. Fischer, H. Bujard, and T. Wirth The B Lymphocyte-Specific Coactivator BOB.1/OBF.1 Is Required at Multiple Stages of B-Cell Development Mol. Cell. Biol., March 1, 2001; 21(5): 1531 - 1539. [Abstract] [Full Text] |
||||
![]() |
K. K. Mann, S. Doerre, J. J. Schlezinger, D. H. Sherr, and S. Quadri The Role of NF-{kappa}B as a Survival Factor in Environmental Chemical-Induced Pre-B Cell Apoptosis Mol. Pharmacol., February 1, 2001; 59(2): 302 - 309. [Abstract] [Full Text] |
||||
![]() |
J. Feuillard, S. Memet, B. Goudeau, A. Lilienbaum, R. Schmidt-Ullrich, M. Raphael, and A. Israel In vivo identification of lymphocyte subsets exhibiting transcriptionally active NF-{kappa}B/Rel complexes Int. Immunol., May 1, 2000; 12(5): 613 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Fields, B. J. Seufzer, E. M. Oltz, and S. Miyamoto A Switch in Distinct I{kappa}B{alpha} Degradation Mechanisms Mediates Constitutive NF-{kappa}B Activation in Mature B Cells J. Immunol., May 1, 2000; 164(9): 4762 - 4767. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Coquilleau, P. Cavelier, F. Rougeon, and M. Goodhardt Comparison of Mouse and Rabbit Ei{kappa} Enhancers Indicates That Different Elements Within the Enhancer May Mediate Activation of Transcription and Recombination J. Immunol., January 15, 2000; 164(2): 795 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Doerre and R. B. Corley Constitutive Nuclear Translocation of NF-{kappa}B in B Cells in the Absence of I{kappa}B Degradation J. Immunol., July 1, 1999; 163(1): 269 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Delfino and W. H. Walker Stage-Specific Nuclear Expression of NF-{kappa}B in Mammalian Testis Mol. Endocrinol., November 1, 1998; 12(11): 1696 - 1707. [Abstract] [Full Text] |
||||
![]() |
B. Baumann, B. Kistler, A. Kirillov, Y. Bergman, and T. Wirth The Mutant Plasmacytoma Cell Line S107 Allows the Identification of Distinct Pathways Leading to NF-kappa B Activation J. Biol. Chem., May 8, 1998; 273(19): 11448 - 11455. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Kurland, R. Kodym, M. D. Story, K. B. Spurgers, T. J. McDonnell, and R. E. Meyn NF-kappa B1 (p50) Homodimers Contribute to Transcription of the bcl-2 Oncogene J. Biol. Chem., November 21, 2001; 276(48): 45380 - 45386. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Solan, H. Miyoshi, E. M. Carmona, G. D. Bren, and C. V. Paya RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100 J. Biol. Chem., January 4, 2002; 277(2): 1405 - 1418. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |